DC Funds, LP
- SEC CIK
- 0001869028
- Latest filing
- Aug 14, 2026
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 12, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 3
- +1 vs. Q2 2021
- Portfolio value
- $25.5M
- +$4.42M (+21.0%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| HOWLWerewolf Therapeutics, Inc. | COM | 589,102 | $10.1M | 39.7% | 00.0% | Unchanged | History |
| BRNSBarinthus Biotherapeutics plc. | ADS | 642,204 | $10.1M | 39.7% | 00.0% | Unchanged | History |
| TCRXTScan Therapeutics, Inc. | COM | 630,000 | $5.25M | 20.6% | +630,000 | New | History |